对tislelizumab的二次排卵性食道炎:一个病例报告
Mingxing Wang1, Qingming Sun1, Wanhui Dong1
1Department of Medical Oncology, Lu'an Hospital of Traditional Chinese Medicine Affiliated To Anhui University of Chinese Medicine, Lu'an, China.
Frontiers in oncology
|December 16, 2024
概括
作为PD-1抑制剂的tislelizumab可以引起罕见的免疫相关不良事件. 本病例报告详细介绍了皮性食道炎,一种新奇的副作用,成功地用皮质类固醇治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 蒂斯莱利祖马布是一种PD-1抑制剂,用于癌症治疗.
- 免疫相关不良事件 (irAEs) 是PD-1抑制剂的已知副作用.
- 食管炎是一种潜在的irAE,但很少与免疫检查点抑制剂 (ICI) 报告.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
103
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
103
Esophageal Strictures-II: Clinical Features and Management
46
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
46


